Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7597091

Concept 2022-03-01 to
2022-05-31
2021-03-01 to
2021-05-31
Consolidated statement of income
Statement of income
Net sales
26,393,000,000 JPY
27,761,000,000 JPY
Cost of sales
11,647,000,000 JPY
11,162,000,000 JPY
Operating expenses
Selling, general and administrative expenses
14,225,000,000 JPY
14,479,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
108,000,000 JPY
159,000,000 JPY
Net sales
Gross profit (loss)
14,745,000,000 JPY
16,599,000,000 JPY
Operating profit (loss)
519,000,000 JPY
2,120,000,000 JPY
Ordinary profit (loss)
2,298,000,000 JPY
2,855,000,000 JPY
Extraordinary income
141,000,000 JPY
659,000,000 JPY
Gain on disposal of non-current assets
141,000,000 JPY
6,000,000 JPY
Non-operating income
Dividend income
83,000,000 JPY
96,000,000 JPY
Interest income
52,000,000 JPY
33,000,000 JPY
Other
136,000,000 JPY
209,000,000 JPY
Non-operating income
1,929,000,000 JPY
924,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
0 JPY
1,000,000 JPY
Other
41,000,000 JPY
28,000,000 JPY
Non-operating expenses
150,000,000 JPY
189,000,000 JPY
Extraordinary losses
41,000,000 JPY
29,000,000 JPY
Loss on disposal of non-current assets
41,000,000 JPY
29,000,000 JPY
Profit (loss) before income taxes
2,398,000,000 JPY
3,485,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
JPY
652,000,000 JPY
Extraordinary losses
Income taxes
657,000,000 JPY
1,050,000,000 JPY
Profit (loss)
1,740,000,000 JPY
2,434,000,000 JPY
Profit (loss) attributable to non-controlling interests
109,000,000 JPY
72,000,000 JPY
Profit (loss) attributable to owners of parent
1,631,000,000 JPY
2,362,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-281,000,000 JPY
-444,000,000 JPY
Foreign currency translation adjustment
4,660,000,000 JPY
4,133,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-26,000,000 JPY
11,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-80,000,000 JPY
-64,000,000 JPY
Other comprehensive income
4,272,000,000 JPY
3,636,000,000 JPY
Profit attributable to
Comprehensive income
6,012,000,000 JPY
6,070,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
5,928,000,000 JPY
6,005,000,000 JPY
Comprehensive income attributable to non-controlling interests
84,000,000 JPY
65,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.